fda statement bpc-157 not approved for human use Survey: Half of Peptide-Users Aren't Aware of Approval Status Federal health advisers are meeting

The discovery that NNMT expression is dramatically elevated in adipose tissue of obese humans and animal models, and that NNMT inhibition or knockdown prevents diet-induced obesity and improves metabolic health, has catalyzed intense research interest in NNMT as a therapeutic target for obesity, metabolic syndrome, and related conditions

It accumulates systemically over days and works through sustained tissue presence, not acute dosing windows

We focus on small-batch synthesis and rigorous third-party testing to guarantee that the peptide in the vial is exactly what it says it is, at the stated purity and quantity

Think of it as a gentle metabolic rebalancer